Psychopharmacology Behavioral effects of benzylideneoxymorphine (BOM), a low efficacy µ opioid receptor agonist and a δ opioid receptor antagonist 2020
Psychopharmacology Methocinnamox (MCAM) antagonizes the behavioral suppressant effects of morphine without impairing delayed matching-to-sample accuracy in rhesus monkeys 2020
Behavioural pharmacology Effects of opioid/cannabinoid mixtures on impulsivity and memory in rhesus monkeys 31, p. 223-248 2020
Behavioural pharmacology Impact of order of fixed-ratio presentation on demand for self-administered remifentanil in male rats. 31, p. 216-220 2020
Journal of Pharmacology and Experimental Therapeutics Methocinnamox (MCAM) produces long-lasting antagonism of the behavioral effects of mu opioid receptor agonists but not prolonged precipitated withdrawal in rats 371, p. 507-516 2019
Behavioural pharmacology Punishment and reinforcement by opioid receptor agonists in a choice procedure in rats 30, p. 335-342 2019